GEODE CAPITAL MANAGEMENT, LLC - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 94 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,070,629
-60.3%
423,120
+4.6%
0.00%
Q2 2023$2,694,969
-62.3%
404,650
+5.6%
0.00%
-100.0%
Q1 2023$7,149,187
+88665.7%
383,129
+2.2%
0.00%0.0%
Q4 2022$8,054
-99.8%
374,999
+5.5%
0.00%0.0%
Q3 2022$4,202,000
-7.4%
355,528
+3.4%
0.00%0.0%
Q2 2022$4,536,000
-30.4%
343,698
+10.3%
0.00%0.0%
Q1 2022$6,515,000
+6.4%
311,587
+3.4%
0.00%0.0%
Q4 2021$6,125,000
-32.1%
301,297
+1.4%
0.00%0.0%
Q3 2021$9,015,000
+12.1%
297,039
+7.3%
0.00%0.0%
Q2 2021$8,044,000
-26.2%
276,819
+9.6%
0.00%
-50.0%
Q1 2021$10,903,000
+5.3%
252,640
+12.7%
0.00%0.0%
Q4 2020$10,359,000
+15.9%
224,237
+8.8%
0.00%0.0%
Q3 2020$8,938,000
+4.5%
206,154
+27.7%
0.00%0.0%
Q2 2020$8,554,000
+182.3%
161,384
+19.0%
0.00%
+100.0%
Q1 2020$3,030,000
+30.9%
135,579
-14.4%
0.00%
Q4 2019$2,314,000
+432.0%
158,408
+155.9%
0.00%
Q3 2019$435,000
-34.3%
61,909
+2.4%
0.00%
Q2 2019$662,000
+164.8%
60,443
+138.5%
0.00%
Q1 2019$250,00025,3420.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Logos Global Management LP 430,000$19,866,0001.70%
APIS CAPITAL ADVISORS, LLC 20,000$924,0000.89%
Avidity Partners Management LP 547,000$25,271,0000.82%
Knoll Capital Management, LLC 20,000$924,0000.63%
Artemis Investment Management LLP 1,013,448$46,839,0000.49%
AlphaCentric Advisors LLC 25,000$1,155,0000.48%
First Light Asset Management, LLC 94,202$4,352,0000.32%
Ikarian Capital, LLC 150,000$6,930,0000.31%
Longitude (Cayman) Ltd. 8,000$370,0000.18%
AllSquare Wealth Management LLC 5,490$254,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders